SecBot SecBot
SECBOTREPLAY Home › Report › DNTH

DNTH · Analysis based on filing metadata only, document content was…

Dianthus Therapeutics, Inc. /DE/ · 8-K filed Mar 12, 2026 at 07:21 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Mar 12, 2026 at 07:21 ET

Analysis based on filing metadata only, document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits), suggesting Dianthus Therapeutics may have entered a significant agreement, but no details are accessible to confirm nature or terms.

  • Filing is Form 8-K with Items 1.01 and 9.01 reported.
  • Item 1.01 indicates a material definitive agreement may have been entered into.
  • Item 9.01 suggests financial statements or exhibits were filed, possibly related to the agreement.
  • No document content available to verify agreement type, parties, or financial terms.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access